Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease

ClinicalTrials.gov ID: NCT02188160

Public ClinicalTrials.gov record NCT02188160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease

Study identification

NCT ID
NCT02188160
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Kala Pharmaceuticals, Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • KPI-121 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2014
Primary completion
Dec 31, 2014
Completion
Feb 28, 2015
Last update posted
Jan 5, 2021

2014 – 2015

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
Sall Research Medical Center Artesia California 90701
North Valley Eye Medical Group Mission Hills California 91345
Martel Eye Medical Group Rancho Cordova California 95670
Eye Center of Southern CT, P.C. Hamden Connecticut 06518
Price Vision Group Indianapolis Indiana 46260
Ophthalmology Associates St Louis Missouri 63131
Comprehensive Eye Care, Ltd. / Vision Research Institute, LLC Washington Missouri 63090
South Shore Eye Center, LLP Wantagh New York 11793
Abrams Eye Center Cleveland Ohio 44115
Total Eye Care, PA Memphis Tennessee 38119
Whitsett Vision Group Houston Texas 77055

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02188160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02188160 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →